This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Kaneka Corporation, National Center for Global Health and Medicine. Active years: 2023-2026.
Company Filing History:
2 out of 1,772 
2 out of 16 Years Active: 2023-2026
Title: Hitoshi Okochi: Innovator in Cell Therapy
Introduction
Hitoshi Okochi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cell therapy, particularly in the production of pancreatic beta cells. His innovative work has led to the development of methods that enhance the therapeutic potential of somatic cells.
Latest Patents
Hitoshi Okochi holds 2 patents. His latest patents include a method for producing pancreatic beta cells and a method for producing a cell population of any of the three germ layers from pluripotent cells. The objective of his inventions is to provide an endodermal cell population that has a reduced content proportion of undifferentiated cells. This endodermal cell population is designed to differentiate into optimal somatic cells for use in cell therapy preparations, which exhibit excellent therapeutic effects.
Career Highlights
Throughout his career, Hitoshi Okochi has worked with notable organizations, including Kaneka Corporation and the National Center for Global Health and Medicine. His experience in these institutions has allowed him to advance his research and contribute to the field of regenerative medicine.
Collaborations
Hitoshi Okochi has collaborated with esteemed colleagues such as Shigeharu Yabe and Satsuki Fukuda. These partnerships have further enriched his research and innovation in cell therapy.
Conclusion
Hitoshi Okochi's work in developing methods for producing pancreatic beta cells and other somatic cells represents a significant advancement in cell therapy. His contributions continue to impact the field positively, paving the way for future innovations.